Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 96 publications
Real-world burden of hypertrophic cardiomyopathy on healthcare use and health-related quality of life in Italy, Spain, and the United States.
Journal: Journal of medical economics
Published: June 01, 2026
Real-World Experience With Mavacamten in SRT-Eligible Obstructive HCM.
Journal: JACC. Advances
Published: April 08, 2026
Proteomics Profiling Reveals Circulating Biomarkers and Dysregulated Pathways in Transthyretin Amyloid Cardiomyopathy.
Journal: Circulation. Heart failure
Published: January 22, 2026
Proteomics Profiling Reveals Circulating Biomarkers and Dysregulated Pathways in Transthyretin Amyloid Cardiomyopathy.
Journal: Circulation. Heart failure
Published: January 22, 2026
Endothelial Cell-Related Proteins in Plasma Predict Major Adverse Cardiovascular Events and Worsening Heart Failure in Patients With Hypertrophic Cardiomyopathy.
Journal: Journal of the American Heart Association
Published: October 09, 2025
Outcomes After Repeat Alcohol Septal Ablation in Patients With Obstructive Hypertrophic Cardiomyopathy.
Journal: JACC. Advances
Published: September 03, 2025
Multiple-Branch Alcohol Septal Ablation Is Associated with Reduced Cardiovascular Events: Insights from a Trans-Pacific Multicentre Registry.
Journal: CJC open
Published: May 26, 2025
Plasma SVEP1 Levels Predict Cardiovascular Events in Hypertrophic Cardiomyopathy Beyond Conventional Clinical Risk Models Including NT-proBNP.
Journal: Circulation. Heart failure
Published: January 20, 2025
Comprehensive Proteomics Profiling Identifies Circulating Biomarkers to Distinguish Hypertrophic Cardiomyopathy From Other Cardiomyopathies With Left Ventricular Hypertrophy.
Journal: Circulation. Heart failure
Published: November 11, 2024
Detection of late gadolinium enhancement in patients with hypertrophic cardiomyopathy using machine learning.
Journal: International journal of cardiology
Published: August 23, 2024
Comprehensive Plasma Proteomic Profiling Reveals Differentially Regulated Signaling Pathways Underlying Left Ventricular Hypertrophy Between Hypertrophic Cardiomyopathy and Aortic Stenosis.
Journal: Journal of cardiovascular translational research
Published: May 30, 2024
Comprehensive Proteomic Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy.
Journal: Journal of the American College of Cardiology
Published: May 01, 2024
Last Updated: 09/26/2026